Status:
COMPLETED
Acupuncture For Pancreatic Cancer Pain
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Pancreatic Neoplasms
Pain
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Pain is a common problem in patients with pancreatic cancer. Some patients suffer from pain despite medication. We, the researchers at Memorial Sloan-Kettering Cancer Center, are conducting a Phase II...
Detailed Description
The main aim of this pancreatic cancer pain trial is to determine the effects of a single, practitioner-given acupuncture treatment followed by semi-permanent acupuncture studs. Our primary endpoint i...
Eligibility Criteria
Inclusion
- Diagnosis of pancreatic adenocarcinoma.
- First baseline current pain score of 3 or above on a 0 - 10 numerical rating scale.
- In the opinion of the treating physician or a medically qualified investigator, the patient's pain syndrome is the result of underlying cancer.
- Patient OR caregiver must be willing and able to apply pressure to each point using small circular movements with the fingers twice per day.
Exclusion
- Primary cause of pain is procedural (e.g. postoperative pain).
- Acupuncture treatment in the past six weeks. Patients should not receive acupuncture during the one week period of the study.
- Neutropenia defined as absolute neutrophil count (ANC) \<1000/microliter.
- Cardiac conditions constituting high or moderate risk of endocarditis as defined by the American Heart Association criteria.
- Patient contraindicated for phlebotomy, as phlebotomy needles are much larger than acupuncture needles.
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00136669
Start Date
September 1 2003
End Date
September 1 2005
Last Update
September 8 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10021